| (Values in U.S. Thousands) | Dec, 2024 | Sep, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
| Sales | 2,350 | 2,260 | 2,420 | 2,150 | 2,130 |
| Sales Growth | +3.98% | -6.61% | +12.56% | +0.94% | -4.05% |
| Net Income | -1,390 | -3,550 | -3,530 | -4,630 | -3,600 |
| Net Income Growth | +60.85% | -0.57% | +23.76% | -28.61% | +23.57% |
Aspira Womans Health Inc
(AWH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Aspira Women's Health Inc. engaged in the discovery, development and commercialization of testing options and bio-analytical solutions for women's health. Aspira Women's Health Inc., formerly known as Vermillion Inc., is based in AUSTIN, Texas.
Fiscal Year End Date: 12/31